v1
TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans.
Identifier:nobleid.org/w1/20260515/4328BF5B
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/4328BF5B)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims